TB-HIV and HIV

35.3 million people are living with HIV today, and HIV infection is a major risk factor for developing TB. The Union works closely with all stakeholders in providing integrated care for the 1.1 million people who need simultaneous treatment for both diseases.  Read more about TB and HIV.

Union Activities

Integrated HIV Care for TB Patients Living with HIV/AIDS

The Union's HIV Department joined international efforts to address the dual epidemic by launching its Integrated HIV Care for Tuberculosis Patients Living with HIV/AIDS (IHC) Programme in 2005. The concept of integrated care entails offering HIV testing and counselling to individuals with tuberculosis who are registered for anti-tuberculosis treatment with a national tuberculosis programme (NTP). This service is also offered to their family/household contacts, including children, as appropriate. If they are found to be HIV positive, TB patients and their contacts are offered integrated HIV care, including antiretroviral therapy.  Read more.

TB-HIV Integrated Care in Zimbabwe

A TB-HIV integrated care project managed by The Union Zimbabwe Office recently announced its second-year results, showing significantly improved care for people requiring simultaneous treatment for both diseases. In a country where an estimated 15% of all 15- to 49-year-olds are HIV positive, and some 74% of the 38,720 tuberculosis patients are co-infected with HIV, this is vital progress. Read more.

ART provided in Myanmar through The Union's "4P" approach

The Union Office in Myanmar, the Myanmar Ministry of Health and their partners passed a milestone in 2012 that once seemed impossible: 10,000 people living with HIV (PLHs) receiving antiretroviral treatment (ART) and other services through the Integrated HIV Care (IHC) Programme. By October 2013, the number had risen to more than 16,000.

The IHC Programme in Myanmar began in 2005 with funding from the Yadana Consortium operated by Total/MGTC. The overarching goal was to scale-up access to ART, but progress was slow at first. After five years, 2,000 patients were on ART. Then The Global Fund and the Three Diseases Fund (3DF) became involved, and 8,000 more patients started on ART between January 2010 and June 2012. Read more.

High-tech HIV diagnostic services in Myanmar

With support from The Union Office in Myanmar, Mandalay’s Public Health Laboratory (PHL) was extensively renovated and equipped with a fully automatic CD4 machine, hematology and biochemistry machines and a molecular laboratory in 2012. A team of pathologists and technicians was trained to use the new equipment, which will enable advanced HIV testing for both diagnosis and treatment monitoring. The PHL serves the estimated 8,000 HIV-infected patients followed by the hospitals in Mandalay’s seven districts. Funding for the equipment, renovations and training came from grants to The Union from the Global Fund to Fight AIDS, TB and Malaria (The Global Fund) and the Fondation Mérieux.

TB-HIV and HIV News

TB-HIV and HIV Publications